Duodenal gastrointestinal stromal tumors (dGISTs) are rare, and a lack of consensus exists regarding their therapeutic management particularly for recurrent disease. We present even low-risk dGIST may metastasize and require long-term observation, and a long-term prognosis may be achieved by combining resection and imatinib therapy for liver metastases recurrence.